SuperworthBenitec Biopharma market cap BNTC
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $301.7M
- Highest close in our data
- $483.7M
- Apr 2026
Benitec Biopharma is worth $301.7M at the close on Oct 23, 2026, at $8.65 a share.
That is down 30% over the last year and up 909% over five years.
Its highest close in our data was $483.7M in Apr 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $301.7M | $282.9M | $483.7M | −32% |
| 2025 | $443.6M | $239.1M | $459.8M | +59% |
| 2024 | $278.6M | $7.3M | $278.6M | +3253% |
| 2023 | $8.3M | $3.6M | $9.8M | +75% |
| 2022 | $4.8M | $1.4M | $23.8M | −78% |
| 2021 | $21.4M | $12.5M | $37M | +62% |
| 2020 | $13.2M | $3M | $13.6M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Benitec Biopharma's size, closest first, today.
| Company | Market cap |
|---|---|
| BNTCBenitec Biopharma | $301.7M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| Peer median | $597.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Benitec Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.